nodes	percent_of_prediction	percent_of_DWPC	metapath
Pethidine—ALB—hematologic cancer	0.09	1	CbGaD
Pethidine—ORM1—Imatinib—hematologic cancer	0.0428	0.0819	CbGbCtD
Pethidine—CYP2B6—Thiotepa—hematologic cancer	0.0339	0.0648	CbGbCtD
Pethidine—CYP2B6—Ifosfamide—hematologic cancer	0.0192	0.0368	CbGbCtD
Pethidine—CYP2D6—Lomustine—hematologic cancer	0.0184	0.0351	CbGbCtD
Pethidine—ALB—Imatinib—hematologic cancer	0.018	0.0344	CbGbCtD
Pethidine—CYP2B6—Nilotinib—hematologic cancer	0.0167	0.0319	CbGbCtD
Pethidine—CYP2D6—Idarubicin—hematologic cancer	0.0164	0.0313	CbGbCtD
Pethidine—CYP2C19—Bortezomib—hematologic cancer	0.0159	0.0305	CbGbCtD
Pethidine—CYP2D6—Hydroxyurea—hematologic cancer	0.0139	0.0266	CbGbCtD
Pethidine—CYP2C19—Thalidomide—hematologic cancer	0.0139	0.0265	CbGbCtD
Pethidine—CYP2C19—Teniposide—hematologic cancer	0.0132	0.0253	CbGbCtD
Pethidine—CYP3A4—Bexarotene—hematologic cancer	0.0126	0.024	CbGbCtD
Pethidine—CYP2C19—Ifosfamide—hematologic cancer	0.0122	0.0234	CbGbCtD
Pethidine—CYP2D6—Bortezomib—hematologic cancer	0.0121	0.0232	CbGbCtD
Pethidine—ALB—Prednisone—hematologic cancer	0.0119	0.0227	CbGbCtD
Pethidine—CYP3A4—Lomustine—hematologic cancer	0.0117	0.0223	CbGbCtD
Pethidine—CYP3A4—Busulfan—hematologic cancer	0.0117	0.0223	CbGbCtD
Pethidine—CYP2C19—Imatinib—hematologic cancer	0.0117	0.0223	CbGbCtD
Pethidine—CYP2B6—Irinotecan—hematologic cancer	0.0115	0.0219	CbGbCtD
Pethidine—ALB—Irinotecan—hematologic cancer	0.0112	0.0215	CbGbCtD
Pethidine—CYP3A4—Thiotepa—hematologic cancer	0.0104	0.0199	CbGbCtD
Pethidine—CYP2B6—Cisplatin—hematologic cancer	0.00935	0.0179	CbGbCtD
Pethidine—CYP2D6—Imatinib—hematologic cancer	0.00887	0.017	CbGbCtD
Pethidine—CYP3A4—Methoxsalen—hematologic cancer	0.00809	0.0155	CbGbCtD
Pethidine—CYP2D6—Nilotinib—hematologic cancer	0.00806	0.0154	CbGbCtD
Pethidine—CYP2D6—Vinorelbine—hematologic cancer	0.00799	0.0153	CbGbCtD
Pethidine—CYP3A4—Bortezomib—hematologic cancer	0.0077	0.0147	CbGbCtD
Pethidine—CYP2C19—Prednisone—hematologic cancer	0.00769	0.0147	CbGbCtD
Pethidine—CYP2B6—Dexamethasone—hematologic cancer	0.00755	0.0145	CbGbCtD
Pethidine—CYP3A4—Daunorubicin—hematologic cancer	0.00736	0.0141	CbGbCtD
Pethidine—CYP3A4—Cytarabine—hematologic cancer	0.0065	0.0124	CbGbCtD
Pethidine—CYP3A4—Teniposide—hematologic cancer	0.0064	0.0122	CbGbCtD
Pethidine—CYP2B6—Doxorubicin—hematologic cancer	0.00627	0.012	CbGbCtD
Pethidine—ALB—Methotrexate—hematologic cancer	0.00595	0.0114	CbGbCtD
Pethidine—CYP3A4—Ifosfamide—hematologic cancer	0.0059	0.0113	CbGbCtD
Pethidine—CYP3A4—Imatinib—hematologic cancer	0.00564	0.0108	CbGbCtD
Pethidine—CYP3A4—Ruxolitinib—hematologic cancer	0.00531	0.0102	CbGbCtD
Pethidine—CYP3A4—Nilotinib—hematologic cancer	0.00513	0.00981	CbGbCtD
Pethidine—CYP3A4—Vinorelbine—hematologic cancer	0.00508	0.00973	CbGbCtD
Pethidine—CYP2D6—Vinblastine—hematologic cancer	0.00493	0.00943	CbGbCtD
Pethidine—CYP2C19—Dexamethasone—hematologic cancer	0.0048	0.00918	CbGbCtD
Pethidine—CYP3A4—Triamcinolone—hematologic cancer	0.00465	0.0089	CbGbCtD
Pethidine—CYP3A4—Dasatinib—hematologic cancer	0.00453	0.00867	CbGbCtD
Pethidine—CYP3A4—Mitoxantrone—hematologic cancer	0.00447	0.00856	CbGbCtD
Pethidine—CYP3A4—Betamethasone—hematologic cancer	0.00399	0.00763	CbGbCtD
Pethidine—CYP3A4—Prednisolone—hematologic cancer	0.00394	0.00753	CbGbCtD
Pethidine—CYP3A4—Prednisone—hematologic cancer	0.00372	0.00711	CbGbCtD
Pethidine—CYP2D6—Dexamethasone—hematologic cancer	0.00365	0.00698	CbGbCtD
Pethidine—CYP3A4—Irinotecan—hematologic cancer	0.00352	0.00674	CbGbCtD
Pethidine—CYP3A4—Vinblastine—hematologic cancer	0.00313	0.00599	CbGbCtD
Pethidine—CYP3A4—Vincristine—hematologic cancer	0.00308	0.00589	CbGbCtD
Pethidine—CYP2D6—Doxorubicin—hematologic cancer	0.00303	0.00579	CbGbCtD
Pethidine—CYP3A4—Etoposide—hematologic cancer	0.00282	0.0054	CbGbCtD
Pethidine—CYP3A4—Dexamethasone—hematologic cancer	0.00232	0.00444	CbGbCtD
Pethidine—CYP3A4—Doxorubicin—hematologic cancer	0.00192	0.00368	CbGbCtD
Pethidine—GRIN2C—testis—hematologic cancer	0.00148	0.0661	CbGeAlD
Pethidine—GRIN2D—testis—hematologic cancer	0.00138	0.0615	CbGeAlD
Pethidine—OPRM1—hematopoietic system—hematologic cancer	0.00113	0.0507	CbGeAlD
Pethidine—ORM1—hematopoietic system—hematologic cancer	0.00111	0.0494	CbGeAlD
Pethidine—SLC6A3—hematopoietic system—hematologic cancer	0.00103	0.046	CbGeAlD
Pethidine—GRIN2A—testis—hematologic cancer	0.00102	0.0457	CbGeAlD
Pethidine—SLC6A4—hematopoietic system—hematologic cancer	0.000944	0.0421	CbGeAlD
Pethidine—CYP2C19—hematopoietic system—hematologic cancer	0.000782	0.0349	CbGeAlD
Pethidine—OPRM1—blood—hematologic cancer	0.000752	0.0336	CbGeAlD
Pethidine—ORM1—blood—hematologic cancer	0.000734	0.0328	CbGeAlD
Pethidine—ORM1—bone marrow—hematologic cancer	0.00071	0.0317	CbGeAlD
Pethidine—ORM1—lung—hematologic cancer	0.000643	0.0287	CbGeAlD
Pethidine—SLC6A2—gonad—hematologic cancer	0.000632	0.0282	CbGeAlD
Pethidine—SLC6A4—blood—hematologic cancer	0.000625	0.0279	CbGeAlD
Pethidine—OPRM1—testis—hematologic cancer	0.000622	0.0278	CbGeAlD
Pethidine—CYP2B6—hematopoietic system—hematologic cancer	0.000612	0.0273	CbGeAlD
Pethidine—SLC6A3—lung—hematologic cancer	0.000598	0.0267	CbGeAlD
Pethidine—SLC6A3—testis—hematologic cancer	0.000564	0.0252	CbGeAlD
Pethidine—SLC6A4—lung—hematologic cancer	0.000548	0.0245	CbGeAlD
Pethidine—ALB—testis—hematologic cancer	0.000532	0.0238	CbGeAlD
Pethidine—CYP2C19—blood—hematologic cancer	0.000518	0.0231	CbGeAlD
Pethidine—SLC6A2—lung—hematologic cancer	0.000483	0.0215	CbGeAlD
Pethidine—CYP2B6—gonad—hematologic cancer	0.000465	0.0208	CbGeAlD
Pethidine—CYP3A4—hematopoietic system—hematologic cancer	0.000462	0.0206	CbGeAlD
Pethidine—SLC6A2—testis—hematologic cancer	0.000455	0.0203	CbGeAlD
Pethidine—CYP2D6—hematopoietic system—hematologic cancer	0.000455	0.0203	CbGeAlD
Pethidine—ORM1—lymph node—hematologic cancer	0.00044	0.0196	CbGeAlD
Pethidine—CYP2B6—blood—hematologic cancer	0.000406	0.0181	CbGeAlD
Pethidine—ALB—lymph node—hematologic cancer	0.000386	0.0172	CbGeAlD
Pethidine—CYP2B6—lung—hematologic cancer	0.000356	0.0159	CbGeAlD
Pethidine—CYP2B6—testis—hematologic cancer	0.000335	0.015	CbGeAlD
Pethidine—SLC6A2—lymph node—hematologic cancer	0.00033	0.0147	CbGeAlD
Pethidine—CYP3A4—blood—hematologic cancer	0.000306	0.0137	CbGeAlD
Pethidine—CYP2D6—blood—hematologic cancer	0.000301	0.0135	CbGeAlD
Pethidine—CYP2D6—testis—hematologic cancer	0.000249	0.0111	CbGeAlD
Pethidine—Anxiety—Dexamethasone—hematologic cancer	6.47e-05	0.00028	CcSEcCtD
Pethidine—Dizziness—Carmustine—hematologic cancer	6.47e-05	0.00028	CcSEcCtD
Pethidine—Constipation—Etoposide—hematologic cancer	6.47e-05	0.00028	CcSEcCtD
Pethidine—Rash—Thalidomide—hematologic cancer	6.42e-05	0.000278	CcSEcCtD
Pethidine—Dermatitis—Thalidomide—hematologic cancer	6.42e-05	0.000278	CcSEcCtD
Pethidine—Dizziness—Alitretinoin—hematologic cancer	6.41e-05	0.000277	CcSEcCtD
Pethidine—Headache—Thalidomide—hematologic cancer	6.38e-05	0.000276	CcSEcCtD
Pethidine—Sweating—Epirubicin—hematologic cancer	6.38e-05	0.000276	CcSEcCtD
Pethidine—Asthenia—Gemcitabine—hematologic cancer	6.36e-05	0.000275	CcSEcCtD
Pethidine—Dizziness—Ifosfamide—hematologic cancer	6.34e-05	0.000274	CcSEcCtD
Pethidine—Pruritus—Gemcitabine—hematologic cancer	6.27e-05	0.000271	CcSEcCtD
Pethidine—Nausea—Thiotepa—hematologic cancer	6.26e-05	0.000271	CcSEcCtD
Pethidine—Feeling abnormal—Etoposide—hematologic cancer	6.24e-05	0.00027	CcSEcCtD
Pethidine—Anaphylactic shock—Dexamethasone—hematologic cancer	6.23e-05	0.000269	CcSEcCtD
Pethidine—Anaphylactic shock—Betamethasone—hematologic cancer	6.23e-05	0.000269	CcSEcCtD
Pethidine—Oedema—Dexamethasone—hematologic cancer	6.23e-05	0.000269	CcSEcCtD
Pethidine—Oedema—Betamethasone—hematologic cancer	6.23e-05	0.000269	CcSEcCtD
Pethidine—Vomiting—Carmustine—hematologic cancer	6.22e-05	0.000269	CcSEcCtD
Pethidine—Insomnia—Triamcinolone—hematologic cancer	6.21e-05	0.000269	CcSEcCtD
Pethidine—Dizziness—Vincristine—hematologic cancer	6.18e-05	0.000267	CcSEcCtD
Pethidine—Rash—Carmustine—hematologic cancer	6.17e-05	0.000267	CcSEcCtD
Pethidine—Dermatitis—Carmustine—hematologic cancer	6.16e-05	0.000267	CcSEcCtD
Pethidine—Vomiting—Alitretinoin—hematologic cancer	6.16e-05	0.000267	CcSEcCtD
Pethidine—Drowsiness—Doxorubicin—hematologic cancer	6.15e-05	0.000266	CcSEcCtD
Pethidine—Feeling abnormal—Prednisolone—hematologic cancer	6.15e-05	0.000266	CcSEcCtD
Pethidine—Visual impairment—Methotrexate—hematologic cancer	6.15e-05	0.000266	CcSEcCtD
Pethidine—Headache—Carmustine—hematologic cancer	6.13e-05	0.000265	CcSEcCtD
Pethidine—Shock—Dexamethasone—hematologic cancer	6.13e-05	0.000265	CcSEcCtD
Pethidine—Shock—Betamethasone—hematologic cancer	6.13e-05	0.000265	CcSEcCtD
Pethidine—Rash—Alitretinoin—hematologic cancer	6.11e-05	0.000264	CcSEcCtD
Pethidine—Agitation—Prednisone—hematologic cancer	6.11e-05	0.000264	CcSEcCtD
Pethidine—Dermatitis—Alitretinoin—hematologic cancer	6.11e-05	0.000264	CcSEcCtD
Pethidine—Vomiting—Ifosfamide—hematologic cancer	6.09e-05	0.000264	CcSEcCtD
Pethidine—Hypersensitivity—Cisplatin—hematologic cancer	6.09e-05	0.000263	CcSEcCtD
Pethidine—Tachycardia—Dexamethasone—hematologic cancer	6.08e-05	0.000263	CcSEcCtD
Pethidine—Tachycardia—Betamethasone—hematologic cancer	6.08e-05	0.000263	CcSEcCtD
Pethidine—Bradycardia—Epirubicin—hematologic cancer	6.08e-05	0.000263	CcSEcCtD
Pethidine—Headache—Alitretinoin—hematologic cancer	6.07e-05	0.000263	CcSEcCtD
Pethidine—Nausea—Thalidomide—hematologic cancer	6.05e-05	0.000262	CcSEcCtD
Pethidine—Rash—Ifosfamide—hematologic cancer	6.04e-05	0.000261	CcSEcCtD
Pethidine—Dermatitis—Ifosfamide—hematologic cancer	6.04e-05	0.000261	CcSEcCtD
Pethidine—Hyperhidrosis—Betamethasone—hematologic cancer	6.02e-05	0.00026	CcSEcCtD
Pethidine—Hyperhidrosis—Dexamethasone—hematologic cancer	6.02e-05	0.00026	CcSEcCtD
Pethidine—Dizziness—Irinotecan—hematologic cancer	6.02e-05	0.00026	CcSEcCtD
Pethidine—Urticaria—Etoposide—hematologic cancer	6.01e-05	0.00026	CcSEcCtD
Pethidine—Vertigo—Prednisone—hematologic cancer	5.97e-05	0.000258	CcSEcCtD
Pethidine—Syncope—Prednisone—hematologic cancer	5.96e-05	0.000258	CcSEcCtD
Pethidine—Vomiting—Vincristine—hematologic cancer	5.94e-05	0.000257	CcSEcCtD
Pethidine—Anorexia—Betamethasone—hematologic cancer	5.94e-05	0.000257	CcSEcCtD
Pethidine—Anorexia—Dexamethasone—hematologic cancer	5.94e-05	0.000257	CcSEcCtD
Pethidine—Urticaria—Prednisolone—hematologic cancer	5.93e-05	0.000257	CcSEcCtD
Pethidine—Asthenia—Cisplatin—hematologic cancer	5.93e-05	0.000256	CcSEcCtD
Pethidine—Sweating—Doxorubicin—hematologic cancer	5.9e-05	0.000255	CcSEcCtD
Pethidine—Rash—Vincristine—hematologic cancer	5.89e-05	0.000255	CcSEcCtD
Pethidine—Dermatitis—Vincristine—hematologic cancer	5.88e-05	0.000255	CcSEcCtD
Pethidine—Headache—Vincristine—hematologic cancer	5.85e-05	0.000253	CcSEcCtD
Pethidine—Loss of consciousness—Prednisone—hematologic cancer	5.84e-05	0.000253	CcSEcCtD
Pethidine—Hypotension—Dexamethasone—hematologic cancer	5.82e-05	0.000252	CcSEcCtD
Pethidine—Hypotension—Betamethasone—hematologic cancer	5.82e-05	0.000252	CcSEcCtD
Pethidine—Nausea—Carmustine—hematologic cancer	5.81e-05	0.000251	CcSEcCtD
Pethidine—Vomiting—Mitoxantrone—hematologic cancer	5.78e-05	0.00025	CcSEcCtD
Pethidine—Vomiting—Irinotecan—hematologic cancer	5.78e-05	0.00025	CcSEcCtD
Pethidine—Nausea—Alitretinoin—hematologic cancer	5.76e-05	0.000249	CcSEcCtD
Pethidine—Convulsion—Prednisone—hematologic cancer	5.76e-05	0.000249	CcSEcCtD
Pethidine—Visual impairment—Epirubicin—hematologic cancer	5.75e-05	0.000249	CcSEcCtD
Pethidine—Hypertension—Prednisone—hematologic cancer	5.74e-05	0.000248	CcSEcCtD
Pethidine—Rash—Mitoxantrone—hematologic cancer	5.74e-05	0.000248	CcSEcCtD
Pethidine—Rash—Irinotecan—hematologic cancer	5.74e-05	0.000248	CcSEcCtD
Pethidine—Dermatitis—Mitoxantrone—hematologic cancer	5.73e-05	0.000248	CcSEcCtD
Pethidine—Dermatitis—Irinotecan—hematologic cancer	5.73e-05	0.000248	CcSEcCtD
Pethidine—Headache—Irinotecan—hematologic cancer	5.7e-05	0.000247	CcSEcCtD
Pethidine—Headache—Mitoxantrone—hematologic cancer	5.7e-05	0.000247	CcSEcCtD
Pethidine—Nausea—Ifosfamide—hematologic cancer	5.69e-05	0.000246	CcSEcCtD
Pethidine—Feeling abnormal—Triamcinolone—hematologic cancer	5.66e-05	0.000245	CcSEcCtD
Pethidine—Anxiety—Prednisone—hematologic cancer	5.64e-05	0.000244	CcSEcCtD
Pethidine—Vomiting—Gemcitabine—hematologic cancer	5.63e-05	0.000244	CcSEcCtD
Pethidine—Insomnia—Dexamethasone—hematologic cancer	5.63e-05	0.000244	CcSEcCtD
Pethidine—Insomnia—Betamethasone—hematologic cancer	5.63e-05	0.000244	CcSEcCtD
Pethidine—Bradycardia—Doxorubicin—hematologic cancer	5.62e-05	0.000243	CcSEcCtD
Pethidine—Rash—Gemcitabine—hematologic cancer	5.59e-05	0.000242	CcSEcCtD
Pethidine—Dermatitis—Gemcitabine—hematologic cancer	5.58e-05	0.000241	CcSEcCtD
Pethidine—Hypersensitivity—Etoposide—hematologic cancer	5.57e-05	0.000241	CcSEcCtD
Pethidine—Erythema—Methotrexate—hematologic cancer	5.55e-05	0.00024	CcSEcCtD
Pethidine—Headache—Gemcitabine—hematologic cancer	5.55e-05	0.00024	CcSEcCtD
Pethidine—Nausea—Vincristine—hematologic cancer	5.55e-05	0.00024	CcSEcCtD
Pethidine—Flushing—Epirubicin—hematologic cancer	5.54e-05	0.00024	CcSEcCtD
Pethidine—Hypersensitivity—Prednisolone—hematologic cancer	5.5e-05	0.000238	CcSEcCtD
Pethidine—Urticaria—Triamcinolone—hematologic cancer	5.45e-05	0.000236	CcSEcCtD
Pethidine—Asthenia—Etoposide—hematologic cancer	5.43e-05	0.000235	CcSEcCtD
Pethidine—Anaphylactic shock—Prednisone—hematologic cancer	5.42e-05	0.000235	CcSEcCtD
Pethidine—Oedema—Prednisone—hematologic cancer	5.42e-05	0.000235	CcSEcCtD
Pethidine—Decreased appetite—Betamethasone—hematologic cancer	5.41e-05	0.000234	CcSEcCtD
Pethidine—Decreased appetite—Dexamethasone—hematologic cancer	5.41e-05	0.000234	CcSEcCtD
Pethidine—Nausea—Mitoxantrone—hematologic cancer	5.4e-05	0.000234	CcSEcCtD
Pethidine—Nausea—Irinotecan—hematologic cancer	5.4e-05	0.000234	CcSEcCtD
Pethidine—Pruritus—Etoposide—hematologic cancer	5.35e-05	0.000232	CcSEcCtD
Pethidine—Shock—Prednisone—hematologic cancer	5.34e-05	0.000231	CcSEcCtD
Pethidine—Visual impairment—Doxorubicin—hematologic cancer	5.32e-05	0.00023	CcSEcCtD
Pethidine—Tachycardia—Prednisone—hematologic cancer	5.29e-05	0.000229	CcSEcCtD
Pethidine—Nausea—Gemcitabine—hematologic cancer	5.26e-05	0.000228	CcSEcCtD
Pethidine—Vomiting—Cisplatin—hematologic cancer	5.25e-05	0.000227	CcSEcCtD
Pethidine—Hyperhidrosis—Prednisone—hematologic cancer	5.24e-05	0.000227	CcSEcCtD
Pethidine—Rash—Cisplatin—hematologic cancer	5.21e-05	0.000225	CcSEcCtD
Pethidine—Dermatitis—Cisplatin—hematologic cancer	5.2e-05	0.000225	CcSEcCtD
Pethidine—Erythema—Epirubicin—hematologic cancer	5.2e-05	0.000225	CcSEcCtD
Pethidine—Anorexia—Prednisone—hematologic cancer	5.17e-05	0.000224	CcSEcCtD
Pethidine—Feeling abnormal—Dexamethasone—hematologic cancer	5.13e-05	0.000222	CcSEcCtD
Pethidine—Feeling abnormal—Betamethasone—hematologic cancer	5.13e-05	0.000222	CcSEcCtD
Pethidine—Flushing—Doxorubicin—hematologic cancer	5.13e-05	0.000222	CcSEcCtD
Pethidine—Hypersensitivity—Triamcinolone—hematologic cancer	5.06e-05	0.000219	CcSEcCtD
Pethidine—Dizziness—Etoposide—hematologic cancer	5e-05	0.000216	CcSEcCtD
Pethidine—Muscle spasms—Epirubicin—hematologic cancer	5e-05	0.000216	CcSEcCtD
Pethidine—Vertigo—Methotrexate—hematologic cancer	4.99e-05	0.000216	CcSEcCtD
Pethidine—Urticaria—Betamethasone—hematologic cancer	4.95e-05	0.000214	CcSEcCtD
Pethidine—Urticaria—Dexamethasone—hematologic cancer	4.95e-05	0.000214	CcSEcCtD
Pethidine—Dizziness—Prednisolone—hematologic cancer	4.94e-05	0.000214	CcSEcCtD
Pethidine—Asthenia—Triamcinolone—hematologic cancer	4.92e-05	0.000213	CcSEcCtD
Pethidine—Nausea—Cisplatin—hematologic cancer	4.91e-05	0.000212	CcSEcCtD
Pethidine—Insomnia—Prednisone—hematologic cancer	4.91e-05	0.000212	CcSEcCtD
Pethidine—Pruritus—Triamcinolone—hematologic cancer	4.86e-05	0.00021	CcSEcCtD
Pethidine—Convulsion—Methotrexate—hematologic cancer	4.81e-05	0.000208	CcSEcCtD
Pethidine—Vomiting—Etoposide—hematologic cancer	4.81e-05	0.000208	CcSEcCtD
Pethidine—Erythema—Doxorubicin—hematologic cancer	4.81e-05	0.000208	CcSEcCtD
Pethidine—Agitation—Epirubicin—hematologic cancer	4.78e-05	0.000207	CcSEcCtD
Pethidine—Rash—Etoposide—hematologic cancer	4.77e-05	0.000206	CcSEcCtD
Pethidine—Dermatitis—Etoposide—hematologic cancer	4.77e-05	0.000206	CcSEcCtD
Pethidine—Headache—Etoposide—hematologic cancer	4.74e-05	0.000205	CcSEcCtD
Pethidine—Decreased appetite—Prednisone—hematologic cancer	4.71e-05	0.000204	CcSEcCtD
Pethidine—Rash—Prednisolone—hematologic cancer	4.71e-05	0.000204	CcSEcCtD
Pethidine—Dermatitis—Prednisolone—hematologic cancer	4.7e-05	0.000203	CcSEcCtD
Pethidine—Headache—Prednisolone—hematologic cancer	4.68e-05	0.000202	CcSEcCtD
Pethidine—Vertigo—Epirubicin—hematologic cancer	4.67e-05	0.000202	CcSEcCtD
Pethidine—Syncope—Epirubicin—hematologic cancer	4.66e-05	0.000202	CcSEcCtD
Pethidine—Constipation—Prednisone—hematologic cancer	4.64e-05	0.000201	CcSEcCtD
Pethidine—Muscle spasms—Doxorubicin—hematologic cancer	4.62e-05	0.0002	CcSEcCtD
Pethidine—Palpitations—Epirubicin—hematologic cancer	4.59e-05	0.000199	CcSEcCtD
Pethidine—Confusional state—Methotrexate—hematologic cancer	4.57e-05	0.000198	CcSEcCtD
Pethidine—Loss of consciousness—Epirubicin—hematologic cancer	4.57e-05	0.000198	CcSEcCtD
Pethidine—Dizziness—Triamcinolone—hematologic cancer	4.54e-05	0.000196	CcSEcCtD
Pethidine—Anaphylactic shock—Methotrexate—hematologic cancer	4.53e-05	0.000196	CcSEcCtD
Pethidine—Convulsion—Epirubicin—hematologic cancer	4.5e-05	0.000195	CcSEcCtD
Pethidine—Nausea—Etoposide—hematologic cancer	4.49e-05	0.000194	CcSEcCtD
Pethidine—Hypertension—Epirubicin—hematologic cancer	4.49e-05	0.000194	CcSEcCtD
Pethidine—Feeling abnormal—Prednisone—hematologic cancer	4.47e-05	0.000193	CcSEcCtD
Pethidine—Asthenia—Dexamethasone—hematologic cancer	4.47e-05	0.000193	CcSEcCtD
Pethidine—Asthenia—Betamethasone—hematologic cancer	4.47e-05	0.000193	CcSEcCtD
Pethidine—Nausea—Prednisolone—hematologic cancer	4.43e-05	0.000192	CcSEcCtD
Pethidine—Agitation—Doxorubicin—hematologic cancer	4.42e-05	0.000191	CcSEcCtD
Pethidine—Anxiety—Epirubicin—hematologic cancer	4.41e-05	0.000191	CcSEcCtD
Pethidine—Pruritus—Betamethasone—hematologic cancer	4.41e-05	0.000191	CcSEcCtD
Pethidine—Pruritus—Dexamethasone—hematologic cancer	4.41e-05	0.000191	CcSEcCtD
Pethidine—Hyperhidrosis—Methotrexate—hematologic cancer	4.38e-05	0.00019	CcSEcCtD
Pethidine—Vomiting—Triamcinolone—hematologic cancer	4.36e-05	0.000189	CcSEcCtD
Pethidine—Rash—Triamcinolone—hematologic cancer	4.33e-05	0.000187	CcSEcCtD
Pethidine—Dry mouth—Epirubicin—hematologic cancer	4.33e-05	0.000187	CcSEcCtD
Pethidine—Dermatitis—Triamcinolone—hematologic cancer	4.32e-05	0.000187	CcSEcCtD
Pethidine—Vertigo—Doxorubicin—hematologic cancer	4.32e-05	0.000187	CcSEcCtD
Pethidine—Anorexia—Methotrexate—hematologic cancer	4.32e-05	0.000187	CcSEcCtD
Pethidine—Syncope—Doxorubicin—hematologic cancer	4.31e-05	0.000187	CcSEcCtD
Pethidine—Urticaria—Prednisone—hematologic cancer	4.31e-05	0.000186	CcSEcCtD
Pethidine—Headache—Triamcinolone—hematologic cancer	4.3e-05	0.000186	CcSEcCtD
Pethidine—Confusional state—Epirubicin—hematologic cancer	4.28e-05	0.000185	CcSEcCtD
Pethidine—Palpitations—Doxorubicin—hematologic cancer	4.25e-05	0.000184	CcSEcCtD
Pethidine—Oedema—Epirubicin—hematologic cancer	4.24e-05	0.000184	CcSEcCtD
Pethidine—Anaphylactic shock—Epirubicin—hematologic cancer	4.24e-05	0.000184	CcSEcCtD
Pethidine—Hypotension—Methotrexate—hematologic cancer	4.24e-05	0.000183	CcSEcCtD
Pethidine—Loss of consciousness—Doxorubicin—hematologic cancer	4.23e-05	0.000183	CcSEcCtD
Pethidine—Shock—Epirubicin—hematologic cancer	4.17e-05	0.000181	CcSEcCtD
Pethidine—Convulsion—Doxorubicin—hematologic cancer	4.17e-05	0.00018	CcSEcCtD
Pethidine—Hypertension—Doxorubicin—hematologic cancer	4.15e-05	0.00018	CcSEcCtD
Pethidine—Tachycardia—Epirubicin—hematologic cancer	4.14e-05	0.000179	CcSEcCtD
Pethidine—Dizziness—Dexamethasone—hematologic cancer	4.12e-05	0.000178	CcSEcCtD
Pethidine—Dizziness—Betamethasone—hematologic cancer	4.12e-05	0.000178	CcSEcCtD
Pethidine—Hyperhidrosis—Epirubicin—hematologic cancer	4.1e-05	0.000177	CcSEcCtD
Pethidine—Insomnia—Methotrexate—hematologic cancer	4.1e-05	0.000177	CcSEcCtD
Pethidine—Anxiety—Doxorubicin—hematologic cancer	4.08e-05	0.000177	CcSEcCtD
Pethidine—Nausea—Triamcinolone—hematologic cancer	4.08e-05	0.000176	CcSEcCtD
Pethidine—Anorexia—Epirubicin—hematologic cancer	4.04e-05	0.000175	CcSEcCtD
Pethidine—Somnolence—Methotrexate—hematologic cancer	4.03e-05	0.000174	CcSEcCtD
Pethidine—Dry mouth—Doxorubicin—hematologic cancer	4e-05	0.000173	CcSEcCtD
Pethidine—Hypersensitivity—Prednisone—hematologic cancer	4e-05	0.000173	CcSEcCtD
Pethidine—Hypotension—Epirubicin—hematologic cancer	3.96e-05	0.000171	CcSEcCtD
Pethidine—Vomiting—Dexamethasone—hematologic cancer	3.96e-05	0.000171	CcSEcCtD
Pethidine—Vomiting—Betamethasone—hematologic cancer	3.96e-05	0.000171	CcSEcCtD
Pethidine—Confusional state—Doxorubicin—hematologic cancer	3.96e-05	0.000171	CcSEcCtD
Pethidine—Decreased appetite—Methotrexate—hematologic cancer	3.94e-05	0.00017	CcSEcCtD
Pethidine—Rash—Betamethasone—hematologic cancer	3.93e-05	0.00017	CcSEcCtD
Pethidine—Rash—Dexamethasone—hematologic cancer	3.93e-05	0.00017	CcSEcCtD
Pethidine—Oedema—Doxorubicin—hematologic cancer	3.92e-05	0.00017	CcSEcCtD
Pethidine—Anaphylactic shock—Doxorubicin—hematologic cancer	3.92e-05	0.00017	CcSEcCtD
Pethidine—Dermatitis—Dexamethasone—hematologic cancer	3.92e-05	0.00017	CcSEcCtD
Pethidine—Dermatitis—Betamethasone—hematologic cancer	3.92e-05	0.00017	CcSEcCtD
Pethidine—Headache—Dexamethasone—hematologic cancer	3.9e-05	0.000169	CcSEcCtD
Pethidine—Headache—Betamethasone—hematologic cancer	3.9e-05	0.000169	CcSEcCtD
Pethidine—Asthenia—Prednisone—hematologic cancer	3.89e-05	0.000168	CcSEcCtD
Pethidine—Shock—Doxorubicin—hematologic cancer	3.86e-05	0.000167	CcSEcCtD
Pethidine—Pruritus—Prednisone—hematologic cancer	3.84e-05	0.000166	CcSEcCtD
Pethidine—Insomnia—Epirubicin—hematologic cancer	3.84e-05	0.000166	CcSEcCtD
Pethidine—Tachycardia—Doxorubicin—hematologic cancer	3.83e-05	0.000166	CcSEcCtD
Pethidine—Hyperhidrosis—Doxorubicin—hematologic cancer	3.79e-05	0.000164	CcSEcCtD
Pethidine—Somnolence—Epirubicin—hematologic cancer	3.77e-05	0.000163	CcSEcCtD
Pethidine—Anorexia—Doxorubicin—hematologic cancer	3.74e-05	0.000162	CcSEcCtD
Pethidine—Feeling abnormal—Methotrexate—hematologic cancer	3.73e-05	0.000162	CcSEcCtD
Pethidine—Nausea—Betamethasone—hematologic cancer	3.7e-05	0.00016	CcSEcCtD
Pethidine—Nausea—Dexamethasone—hematologic cancer	3.7e-05	0.00016	CcSEcCtD
Pethidine—Decreased appetite—Epirubicin—hematologic cancer	3.69e-05	0.00016	CcSEcCtD
Pethidine—Hypotension—Doxorubicin—hematologic cancer	3.67e-05	0.000159	CcSEcCtD
Pethidine—Constipation—Epirubicin—hematologic cancer	3.63e-05	0.000157	CcSEcCtD
Pethidine—Urticaria—Methotrexate—hematologic cancer	3.6e-05	0.000156	CcSEcCtD
Pethidine—Dizziness—Prednisone—hematologic cancer	3.59e-05	0.000155	CcSEcCtD
Pethidine—Insomnia—Doxorubicin—hematologic cancer	3.55e-05	0.000154	CcSEcCtD
Pethidine—Feeling abnormal—Epirubicin—hematologic cancer	3.5e-05	0.000151	CcSEcCtD
Pethidine—Somnolence—Doxorubicin—hematologic cancer	3.49e-05	0.000151	CcSEcCtD
Pethidine—Vomiting—Prednisone—hematologic cancer	3.45e-05	0.000149	CcSEcCtD
Pethidine—Rash—Prednisone—hematologic cancer	3.42e-05	0.000148	CcSEcCtD
Pethidine—Dermatitis—Prednisone—hematologic cancer	3.42e-05	0.000148	CcSEcCtD
Pethidine—Decreased appetite—Doxorubicin—hematologic cancer	3.41e-05	0.000148	CcSEcCtD
Pethidine—Headache—Prednisone—hematologic cancer	3.4e-05	0.000147	CcSEcCtD
Pethidine—Urticaria—Epirubicin—hematologic cancer	3.37e-05	0.000146	CcSEcCtD
Pethidine—Constipation—Doxorubicin—hematologic cancer	3.36e-05	0.000145	CcSEcCtD
Pethidine—Hypersensitivity—Methotrexate—hematologic cancer	3.34e-05	0.000144	CcSEcCtD
Pethidine—Asthenia—Methotrexate—hematologic cancer	3.25e-05	0.000141	CcSEcCtD
Pethidine—Feeling abnormal—Doxorubicin—hematologic cancer	3.23e-05	0.00014	CcSEcCtD
Pethidine—Nausea—Prednisone—hematologic cancer	3.22e-05	0.000139	CcSEcCtD
Pethidine—Pruritus—Methotrexate—hematologic cancer	3.21e-05	0.000139	CcSEcCtD
Pethidine—Hypersensitivity—Epirubicin—hematologic cancer	3.13e-05	0.000135	CcSEcCtD
Pethidine—Urticaria—Doxorubicin—hematologic cancer	3.12e-05	0.000135	CcSEcCtD
Pethidine—Asthenia—Epirubicin—hematologic cancer	3.04e-05	0.000132	CcSEcCtD
Pethidine—Pruritus—Epirubicin—hematologic cancer	3e-05	0.00013	CcSEcCtD
Pethidine—Dizziness—Methotrexate—hematologic cancer	3e-05	0.00013	CcSEcCtD
Pethidine—Hypersensitivity—Doxorubicin—hematologic cancer	2.89e-05	0.000125	CcSEcCtD
Pethidine—Vomiting—Methotrexate—hematologic cancer	2.88e-05	0.000125	CcSEcCtD
Pethidine—Rash—Methotrexate—hematologic cancer	2.86e-05	0.000124	CcSEcCtD
Pethidine—Dermatitis—Methotrexate—hematologic cancer	2.86e-05	0.000124	CcSEcCtD
Pethidine—Headache—Methotrexate—hematologic cancer	2.84e-05	0.000123	CcSEcCtD
Pethidine—Asthenia—Doxorubicin—hematologic cancer	2.82e-05	0.000122	CcSEcCtD
Pethidine—Dizziness—Epirubicin—hematologic cancer	2.8e-05	0.000121	CcSEcCtD
Pethidine—Pruritus—Doxorubicin—hematologic cancer	2.78e-05	0.00012	CcSEcCtD
Pethidine—Vomiting—Epirubicin—hematologic cancer	2.7e-05	0.000117	CcSEcCtD
Pethidine—Nausea—Methotrexate—hematologic cancer	2.69e-05	0.000116	CcSEcCtD
Pethidine—Rash—Epirubicin—hematologic cancer	2.67e-05	0.000116	CcSEcCtD
Pethidine—Dermatitis—Epirubicin—hematologic cancer	2.67e-05	0.000116	CcSEcCtD
Pethidine—Headache—Epirubicin—hematologic cancer	2.66e-05	0.000115	CcSEcCtD
Pethidine—Dizziness—Doxorubicin—hematologic cancer	2.6e-05	0.000112	CcSEcCtD
Pethidine—Nausea—Epirubicin—hematologic cancer	2.52e-05	0.000109	CcSEcCtD
Pethidine—Vomiting—Doxorubicin—hematologic cancer	2.5e-05	0.000108	CcSEcCtD
Pethidine—Rash—Doxorubicin—hematologic cancer	2.47e-05	0.000107	CcSEcCtD
Pethidine—Dermatitis—Doxorubicin—hematologic cancer	2.47e-05	0.000107	CcSEcCtD
Pethidine—Headache—Doxorubicin—hematologic cancer	2.46e-05	0.000106	CcSEcCtD
Pethidine—Nausea—Doxorubicin—hematologic cancer	2.33e-05	0.000101	CcSEcCtD
Pethidine—OPRM1—Signaling Pathways—TERT—hematologic cancer	4.92e-06	3.68e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CD80—hematologic cancer	4.92e-06	3.67e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KIT—hematologic cancer	4.91e-06	3.67e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CG—hematologic cancer	4.91e-06	3.67e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—NRAS—hematologic cancer	4.91e-06	3.67e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ABCG2—hematologic cancer	4.87e-06	3.64e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—MTR—hematologic cancer	4.87e-06	3.64e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AGRN—hematologic cancer	4.85e-06	3.62e-05	CbGpPWpGaD
Pethidine—ALB—Platelet activation, signaling and aggregation—AKT1—hematologic cancer	4.85e-06	3.62e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PTPN11—hematologic cancer	4.82e-06	3.6e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PDGFB—hematologic cancer	4.8e-06	3.59e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ENO2—hematologic cancer	4.78e-06	3.57e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.71e-06	3.51e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—MAPK3—hematologic cancer	4.7e-06	3.51e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TSC2—hematologic cancer	4.7e-06	3.51e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CREB1—hematologic cancer	4.67e-06	3.49e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—NQO1—hematologic cancer	4.67e-06	3.49e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CD44—hematologic cancer	4.67e-06	3.49e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.64e-06	3.47e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTT1—hematologic cancer	4.64e-06	3.46e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTP1—hematologic cancer	4.62e-06	3.45e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—BRAF—hematologic cancer	4.61e-06	3.45e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—IL2—hematologic cancer	4.61e-06	3.44e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—IDH2—hematologic cancer	4.6e-06	3.43e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HMMR—hematologic cancer	4.6e-06	3.43e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCL2—hematologic cancer	4.57e-06	3.41e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.57e-06	3.41e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL6R—hematologic cancer	4.56e-06	3.4e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CREBBP—hematologic cancer	4.55e-06	3.4e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—SDC1—hematologic cancer	4.53e-06	3.38e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—FGFR3—hematologic cancer	4.52e-06	3.37e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAPK14—hematologic cancer	4.47e-06	3.34e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.44e-06	3.32e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CYCS—hematologic cancer	4.41e-06	3.3e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—ESR1—hematologic cancer	4.39e-06	3.28e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—HSP90AA1—hematologic cancer	4.39e-06	3.28e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ABCB1—hematologic cancer	4.38e-06	3.27e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MAP2K1—hematologic cancer	4.34e-06	3.24e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—FN1—hematologic cancer	4.33e-06	3.24e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.32e-06	3.23e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CD—hematologic cancer	4.31e-06	3.22e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—BAD—hematologic cancer	4.28e-06	3.2e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NFKBIA—hematologic cancer	4.28e-06	3.2e-05	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—PIK3CA—hematologic cancer	4.27e-06	3.19e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—NCOR1—hematologic cancer	4.25e-06	3.17e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—GSTM1—hematologic cancer	4.25e-06	3.17e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NOTCH1—hematologic cancer	4.24e-06	3.17e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—KRAS—hematologic cancer	4.22e-06	3.15e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CA9—hematologic cancer	4.2e-06	3.14e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ACP5—hematologic cancer	4.2e-06	3.14e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CD44—hematologic cancer	4.19e-06	3.13e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NQO1—hematologic cancer	4.19e-06	3.13e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CD80—hematologic cancer	4.15e-06	3.1e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NCOR2—hematologic cancer	4.15e-06	3.1e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CG—hematologic cancer	4.15e-06	3.1e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KIT—hematologic cancer	4.15e-06	3.1e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—NRAS—hematologic cancer	4.15e-06	3.1e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—EP300—hematologic cancer	4.14e-06	3.09e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—FGF2—hematologic cancer	4.13e-06	3.09e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.1e-06	3.06e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PTPN11—hematologic cancer	4.07e-06	3.04e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3R1—hematologic cancer	4.07e-06	3.04e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—SRC—hematologic cancer	4.02e-06	3e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—MAPK3—hematologic cancer	3.97e-06	2.97e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CYCS—hematologic cancer	3.96e-06	2.96e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—JAK2—hematologic cancer	3.96e-06	2.96e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—IDH1—hematologic cancer	3.95e-06	2.95e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.95e-06	2.95e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CREB1—hematologic cancer	3.95e-06	2.95e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—HSP90AA1—hematologic cancer	3.94e-06	2.94e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—VEGFA—hematologic cancer	3.92e-06	2.93e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.91e-06	2.92e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.91e-06	2.92e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—TXN—hematologic cancer	3.91e-06	2.92e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—BRAF—hematologic cancer	3.9e-06	2.91e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTP1—hematologic cancer	3.89e-06	2.91e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—PIK3CA—hematologic cancer	3.88e-06	2.9e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—NRAS—hematologic cancer	3.87e-06	2.89e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MDM2—hematologic cancer	3.86e-06	2.89e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCL2—hematologic cancer	3.86e-06	2.89e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NQO1—hematologic cancer	3.85e-06	2.88e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CD44—hematologic cancer	3.85e-06	2.88e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL6R—hematologic cancer	3.85e-06	2.88e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CREBBP—hematologic cancer	3.84e-06	2.87e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.82e-06	2.86e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.76e-06	2.81e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CB—hematologic cancer	3.76e-06	2.81e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MTOR—hematologic cancer	3.76e-06	2.81e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—MTHFR—hematologic cancer	3.75e-06	2.8e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—MAPK3—hematologic cancer	3.71e-06	2.77e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—ABCB1—hematologic cancer	3.68e-06	2.75e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.67e-06	2.75e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAP2K1—hematologic cancer	3.67e-06	2.74e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CD—hematologic cancer	3.65e-06	2.72e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CYCS—hematologic cancer	3.65e-06	2.72e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	3.62e-06	2.71e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—PIK3CA—hematologic cancer	3.61e-06	2.7e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TGFB1—hematologic cancer	3.59e-06	2.69e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—HRAS—hematologic cancer	3.59e-06	2.68e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—NCOR1—hematologic cancer	3.58e-06	2.67e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—GSTM1—hematologic cancer	3.58e-06	2.67e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.57e-06	2.67e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.57e-06	2.67e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—KRAS—hematologic cancer	3.57e-06	2.67e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.54e-06	2.65e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CDKN1B—hematologic cancer	3.53e-06	2.64e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTP1—hematologic cancer	3.49e-06	2.61e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—FGF2—hematologic cancer	3.49e-06	2.61e-05	CbGpPWpGaD
Pethidine—OPRK1—GPCR downstream signaling—AKT1—hematologic cancer	3.49e-06	2.61e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.48e-06	2.6e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CASP3—hematologic cancer	3.46e-06	2.58e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL2—hematologic cancer	3.45e-06	2.58e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3R1—hematologic cancer	3.44e-06	2.57e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—IL6—hematologic cancer	3.44e-06	2.57e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.38e-06	2.52e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NUP98—hematologic cancer	3.37e-06	2.52e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CCND1—hematologic cancer	3.37e-06	2.51e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—JUN—hematologic cancer	3.36e-06	2.51e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—JAK2—hematologic cancer	3.35e-06	2.5e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—KRAS—hematologic cancer	3.33e-06	2.49e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ABCB1—hematologic cancer	3.31e-06	2.47e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—PIK3CA—hematologic cancer	3.28e-06	2.45e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.28e-06	2.45e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.28e-06	2.45e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MDM2—hematologic cancer	3.27e-06	2.44e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—CDKN1A—hematologic cancer	3.26e-06	2.43e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NUP214—hematologic cancer	3.25e-06	2.43e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PTEN—hematologic cancer	3.25e-06	2.43e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTP1—hematologic cancer	3.21e-06	2.4e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—NCOR1—hematologic cancer	3.21e-06	2.4e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—GSTM1—hematologic cancer	3.21e-06	2.4e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.19e-06	2.38e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MTR—hematologic cancer	3.19e-06	2.38e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MAPK8—hematologic cancer	3.18e-06	2.37e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CB—hematologic cancer	3.18e-06	2.37e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MTOR—hematologic cancer	3.18e-06	2.37e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling by GPCR—AKT1—hematologic cancer	3.17e-06	2.37e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—MTHFR—hematologic cancer	3.16e-06	2.36e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CG—hematologic cancer	3.15e-06	2.36e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ENO2—hematologic cancer	3.12e-06	2.33e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—EP300—hematologic cancer	3.1e-06	2.31e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—PIK3CA—hematologic cancer	3.06e-06	2.29e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ABCB1—hematologic cancer	3.04e-06	2.27e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—HRAS—hematologic cancer	3.03e-06	2.27e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTT1—hematologic cancer	3.03e-06	2.26e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—SRC—hematologic cancer	3.01e-06	2.25e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CDKN1B—hematologic cancer	2.98e-06	2.23e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—SDC1—hematologic cancer	2.96e-06	2.21e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—TP53—hematologic cancer	2.96e-06	2.21e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.95e-06	2.21e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.95e-06	2.21e-05	CbGpPWpGaD
Pethidine—OPRM1—GPCR downstream signaling—AKT1—hematologic cancer	2.95e-06	2.2e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—VEGFA—hematologic cancer	2.93e-06	2.19e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—CREBBP—hematologic cancer	2.92e-06	2.18e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CASP3—hematologic cancer	2.92e-06	2.18e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL2—hematologic cancer	2.92e-06	2.18e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—STAT3—hematologic cancer	2.91e-06	2.17e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—IL6—hematologic cancer	2.9e-06	2.17e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—NRAS—hematologic cancer	2.9e-06	2.17e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CCND1—hematologic cancer	2.84e-06	2.12e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—JUN—hematologic cancer	2.84e-06	2.12e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—MTHFR—hematologic cancer	2.84e-06	2.12e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—HRAS—hematologic cancer	2.83e-06	2.11e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.79e-06	2.08e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MAPK3—hematologic cancer	2.78e-06	2.07e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CD—hematologic cancer	2.77e-06	2.07e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—CDKN1A—hematologic cancer	2.75e-06	2.06e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PTEN—hematologic cancer	2.75e-06	2.05e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—ALB—hematologic cancer	2.74e-06	2.04e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—MYC—hematologic cancer	2.7e-06	2.02e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TGFB1—hematologic cancer	2.69e-06	2.01e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAPK8—hematologic cancer	2.69e-06	2.01e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling by GPCR—AKT1—hematologic cancer	2.68e-06	2e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CG—hematologic cancer	2.66e-06	1.98e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—EP300—hematologic cancer	2.62e-06	1.96e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3R1—hematologic cancer	2.62e-06	1.96e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—MTHFR—hematologic cancer	2.61e-06	1.95e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—SRC—hematologic cancer	2.55e-06	1.9e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NQO1—hematologic cancer	2.52e-06	1.88e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CD44—hematologic cancer	2.52e-06	1.88e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.5e-06	1.87e-05	CbGpPWpGaD
Pethidine—ALB—Hemostasis—AKT1—hematologic cancer	2.5e-06	1.87e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—KRAS—hematologic cancer	2.49e-06	1.86e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—VEGFA—hematologic cancer	2.48e-06	1.85e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—CREBBP—hematologic cancer	2.46e-06	1.84e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—STAT3—hematologic cancer	2.46e-06	1.83e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—NRAS—hematologic cancer	2.45e-06	1.83e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CB—hematologic cancer	2.42e-06	1.81e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CG—hematologic cancer	2.38e-06	1.78e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CYCS—hematologic cancer	2.38e-06	1.78e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.37e-06	1.77e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MAPK3—hematologic cancer	2.35e-06	1.75e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CD—hematologic cancer	2.33e-06	1.74e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—PIK3CA—hematologic cancer	2.29e-06	1.71e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—MYC—hematologic cancer	2.28e-06	1.7e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TGFB1—hematologic cancer	2.28e-06	1.7e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—TP53—hematologic cancer	2.22e-06	1.66e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—CREBBP—hematologic cancer	2.21e-06	1.65e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3R1—hematologic cancer	2.2e-06	1.65e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CG—hematologic cancer	2.19e-06	1.64e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—HRAS—hematologic cancer	2.12e-06	1.58e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—KRAS—hematologic cancer	2.11e-06	1.57e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.1e-06	1.57e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CD—hematologic cancer	2.1e-06	1.57e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PTEN—hematologic cancer	2.09e-06	1.56e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—ALB—hematologic cancer	2.07e-06	1.55e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CB—hematologic cancer	2.03e-06	1.52e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—CREBBP—hematologic cancer	2.03e-06	1.52e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—IL6—hematologic cancer	2.03e-06	1.52e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—EP300—hematologic cancer	1.99e-06	1.49e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.99e-06	1.49e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3R1—hematologic cancer	1.98e-06	1.48e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—PIK3CA—hematologic cancer	1.94e-06	1.45e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.93e-06	1.44e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.93e-06	1.44e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.93e-06	1.44e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—ALB—hematologic cancer	1.9e-06	1.42e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—TP53—hematologic cancer	1.87e-06	1.4e-05	CbGpPWpGaD
Pethidine—OPRK1—Signaling Pathways—AKT1—hematologic cancer	1.87e-06	1.4e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CB—hematologic cancer	1.83e-06	1.36e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.82e-06	1.36e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—HRAS—hematologic cancer	1.79e-06	1.34e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—PTEN—hematologic cancer	1.76e-06	1.31e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—IL6—hematologic cancer	1.72e-06	1.28e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.71e-06	1.27e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.68e-06	1.25e-05	CbGpPWpGaD
Pethidine—ALB—Metabolism—EP300—hematologic cancer	1.68e-06	1.25e-05	CbGpPWpGaD
Pethidine—OPRM1—Signaling Pathways—AKT1—hematologic cancer	1.58e-06	1.18e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PTEN—hematologic cancer	1.58e-06	1.18e-05	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—EP300—hematologic cancer	1.51e-06	1.12e-05	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—PIK3CA—hematologic cancer	1.47e-06	1.1e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PTEN—hematologic cancer	1.45e-06	1.08e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.43e-06	1.07e-05	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—EP300—hematologic cancer	1.38e-06	1.03e-05	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.33e-06	9.93e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.26e-06	9.41e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—ALB—hematologic cancer	1.24e-06	9.29e-06	CbGpPWpGaD
Pethidine—ALB—Metabolism—PIK3CA—hematologic cancer	1.24e-06	9.26e-06	CbGpPWpGaD
Pethidine—CYP2B6—Metabolism—AKT1—hematologic cancer	1.2e-06	8.99e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.19e-06	8.89e-06	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—PIK3CA—hematologic cancer	1.11e-06	8.32e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.1e-06	8.2e-06	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—PIK3CA—hematologic cancer	1.02e-06	7.65e-06	CbGpPWpGaD
Pethidine—ALB—Metabolism—AKT1—hematologic cancer	1.01e-06	7.57e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PTEN—hematologic cancer	9.49e-07	7.09e-06	CbGpPWpGaD
Pethidine—CYP2C19—Metabolism—AKT1—hematologic cancer	9.1e-07	6.79e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—EP300—hematologic cancer	9.05e-07	6.76e-06	CbGpPWpGaD
Pethidine—CYP2D6—Metabolism—AKT1—hematologic cancer	8.37e-07	6.25e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.7e-07	5e-06	CbGpPWpGaD
Pethidine—CYP3A4—Metabolism—AKT1—hematologic cancer	5.47e-07	4.09e-06	CbGpPWpGaD
